BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6198872)

  • 1. [Management of the chronic carrier of hepatitis B surface antigen (HBsAg)].
    Ramalho F
    Acta Med Port; 1983; 4(11-12):501-8. PubMed ID: 6198872
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
    Lu JH
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
    Lu JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cohort study on the relation of primary liver cancer and HBsAg positivity in Guangxi Province].
    Zhang ZQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):141-2. PubMed ID: 2555118
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 11. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of alpha-fetoprotein in chronic HBsAg carriers].
    Stránský J; Vodák M; Zichová M
    Vnitr Lek; 1988 Nov; 34(11):1076-81. PubMed ID: 2462764
    [No Abstract]   [Full Text] [Related]  

  • 13. Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
    Dusheiko GM; Conradie JC; Bowyer SM; Simjee A; Epstein B; Levien LJ; Beale P; Kew MC
    S Afr Med J; 1986 Jan; 69(2):129-32. PubMed ID: 2417341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
    Maggi G; Bighellini K; Borghi L
    Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term trend of decreasing frequency of hepatitis B virus infection.
    Senba M; Nakamura T; Senba MI; Watanabe M; Zhong X; Itakura H
    Acta Virol; 1993; 37(2-3):199-201. PubMed ID: 8105668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
    Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
    Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia.
    Tsega E; Gold P; Shuster J; Whittemore B; Lester FT
    J Trop Med Hyg; 1976 Oct; 79(10):230-4. PubMed ID: 64619
    [No Abstract]   [Full Text] [Related]  

  • 19. [What is the disease course in carriers of HBsAg?].
    González A; Guardia J
    Med Clin (Barc); 1989 Dec; 93(19):737-40. PubMed ID: 2560101
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of hepatitis B surface antigen carriers in a cohort.
    Iijima T; Nambu M
    Trop Gastroenterol; 1988; 9(4):196-8. PubMed ID: 2851885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.